Fundraising Fox

AIQ

New York, US · Founded 2010 · 6 known investors

aiq-solutions.com

AIQ Solutions develops TRAQinform IQ, a software medical device that analyzes serial radiographic images (such as PET and CT scans) to quantify changes in individual tumor lesions over time. The cloud-based, HIPAA-compliant tool generates reports that oncologists and clinicians use to adjust therapies and optimize late-stage cancer treatment.

AI & Machine LearningHealthtechMedical Devicesin /aiqsolutions@aiq_solutions

Founders & leadership

WO
William O'ConorMember of the Board of Directors
TG
T. Gary LibermanChief Financial Officer and Secretary
NW
Nicholas W. StullerChief Executive Officer

Investors · 6

Reported raises · per SEC filings

Form D private placements

$1.5M disclosed across 1 round · 2014

$1.5MraisedApr 2014 · 13 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • William O'ConorDirector
  • T. Gary LibermanExecutive Officer
  • Nicholas W. StullerExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$1.5M
First sale
Mar 2014
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2023$881.6K
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$2M
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$388.3K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does AIQ do?
AIQ Solutions develops TRAQinform IQ, a software medical device that analyzes serial radiographic images (such as PET and CT scans) to quantify changes in individual tumor lesions over time. The cloud-based, HIPAA-compliant tool generates reports that oncologists and clinicians use to adjust therapies and optimize late-stage cancer treatment.
Who are AIQ's investors?
AIQ's investors include Aurora Forge, Capital Midwest Fund, New York Angels, Rock River Capital Partners, Tundra Angels, Venture Management.
How much funding has AIQ raised?
AIQ has disclosed $1.5M raised across 1 round.
Where is AIQ headquartered?
AIQ is headquartered in New York, US.